11th Annual Drug Discovery Leaders Summit
Venue: Le Montreux Palace
|Event Date/Time: Jun 09, 2010||End Date/Time: Jun 10, 2010|
In keeping with Oxford Globalâ€™s highly successful drug discovery series, an expert panel of speakers will present a full conference programme covering science, technology, strategy, data management and informatics, allowing attendees to gain an essential industry update. Key topics include:
R & D Strategies & Pharm/Biotech Alliances Collaborations & Outsourcing
â€“ Strategies to enhance drug discovery, overcoming attrition, prediction tools that drive clear decisive rules, risk management.
â€“ GPCRâ€™s, RNAi, and Proteins Kinases, reducing risk of toxicity, structure based discovery, hit to lead strategies, fragment based techniques.
Screening techniques & Assay Development
â€“ Improving quality of assays, cost effective HTS & HCS, moving towards more complex systems.
â€“ Successful partnerships, managing alliances, balancing conflicting interests, biotech technology platforms.
Biomarkers & Translational Medicine
- Personalised medicine, decision making tools, surrogate end points, translation strategies, validation, biobanking.
- In-silico data, data mining, predictive modelling.
Who will attend?
Delegates are pre-qualified dependent on budget, responsibility and seniority. Delegates are senior-level decision makers, from major pharmaceutical and biotech companies based in Europe and typically include SVPs, VPs and Directors of:
Drug Discovery, Biomarkers, Medicinal Chemistry, Screening, Strategic Alliances, R&D, Screening ,Enabling Technologies, Genomics, Enabling Science Informatics, Toxicology, Portfolio Management, Proteomics, Structural Biology Systems Biology, Translational Medicine, Assay Development, Bioinformatics, Lead Generation/ Validation/ Optimisation